A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Part of paid clinical trials in Beverly Hills, California.
- Sponsor
- Genentech, Inc.
- Study ID
- NCT07448038
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Atherosclerosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Selnoflast — DRUGSelnoflast will be administered as per the schedule specified in the respective arm.
- Placebo — DRUGPlacebo will be administered as per the schedule specified in the respective arm.
Study Details
The main purpose of the study is to evaluate the efficacy of selnoflast compared with placebo in participants with atherosclerosis, at high-risk for major adverse cardiovascular event (MACE), who are currently on standard-of-care (SOC) therapy.
Key Dates
- First listed
- Mar 4, 2026
- Start date
- Jun 5, 2026
- Status verified
- Sep 2026
- Primary completion
- Jan 31, 2028
- Completion
- Feb 28, 2028
Study Design
- Enrollment
- 162 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: SelnoflastParticipants will receive selnoflast, orally (PO), twice a day (BID) for 12 weeks.
- Placebo Comparator: PlaceboParticipants will receive placebo, PO, BID for 12 weeks.
Primary Outcome Measure
Change in mdsTBR (Most-diseased Segment TBR [Target-to-background Ratio]) of Index Vessel From Baseline to Week 12 in Participants With Baseline Elevated hsCRP (≥ 2 milligrams per liter [mg/L]) [ Time Frame: Baseline up to Week 12 ]
Central Contacts
- Reference Study ID Number: GC46102 https://forpatients.roche.com/888-662-6728
- Fastest response: use the inquiry form. No email attachments https://www.gene.com/contact-us/submit-medical-inquiry
Locations (23)
Find similar trials in Beverly Hills, CA
By research site
Cardiovascular Research Foundation of Southern California· Beverly Hills, CANational Heart Institute· Beverly Hills, CAAmnova Clinical Research· Irvine, CANorthBay Clinical Research· Santa Rosa, CAAlliance Clinical West Hills (Focus Clinical Research)· West Hills, CAYale University School of Medicine Yale-New Haven Hospital (YNHH) - Smilow Cancer Hospital· New Haven, CT
Related Studies
- Study of the Effect of Innate on the Inflammatory Response to EndotoxinRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina
- Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPHASE4 · Recruiting · VA Office of Research and Development · Phoenix, Arizona
- High Protein Diet and AtherosclerosisRecruiting · University of Missouri-Columbia · Columbia, Missouri
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)PHASE2 · Recruiting · Priscilla Hsue, MD · Los Angeles, California